Thai badminton star Pitchamon Opatniputh has been provisionally suspended after returning a positive doping sample containing furosemide, a prohibited diuretic, ahead of the upcoming international fixtures. The International Testing Agency (ITA) announced the finding via its official channels, detailing that the banned substance violates global anti-doping regulations.
Provisional Suspension Handed Down
Out-of-Competition Testing Triggers ITA Action
According to the International Testing Agency, routine out-of-competition testing flagged the presence of furosemide in the athlete’s biological sample. The banned substance falls under the World Anti-Doping Agency (WADA) prohibited list as a specified diuretic and masking agent, which is strictly restricted due to its potential to dilute urine or conceal the presence of other performance-enhancing drugs.
B-Sample Rights and Tournament Bans
The provisional suspension prevents Opatniputh from competing in sanctioned badminton tournaments while the investigation continues. Under standard anti-doping protocols managed by independent testing bodies, athletes facing such findings retain the right to request the analysis of a B sample to confirm or refute the initial screening results. Governing bodies have not yet released a definitive timeline for the disciplinary hearings.

Junior Circuit Success and Senior Transition
Recognized as one of Thailand’s rising talents on the international circuit, Opatniputh has built a notable junior and senior career profile. Her past achievements include strong performances on the Badminton World Federation (BWF) junior tour, where she captured significant age-group titles before transitioning to senior-level competitions across Asia and Europe.
Pending Review Panels and Formal Portals
The case now moves to formal review panels where legal representatives and sports authorities will examine the source of the substance. Official updates regarding any scheduled hearings or B-sample testing results will be published directly through international anti-doping portals.
Keep reading